Monica Bhatia

Monica Bhatia

Pediatrics

161 Fort Washington Avenue
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.

Journal: Transplantation and cellular therapy

Published: March 16, 2026

Living Donor Liver Transplantation as Salvage Therapy for Steroid-Refractory Chronic Hepatic GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation.

Living Donor Liver Transplantation as Salvage Therapy for Steroid-Refractory Chronic Hepatic GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Pediatric transplantation

Published: February 18, 2026

G-CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution.

G-CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution.

Journal: American journal of hematology

Published: January 19, 2026

Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease.

Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease.

Journal: Transplantation and cellular therapy

Published: November 17, 2025

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.

Journal: American journal of hematology

Published: September 25, 2025

It Takes a Village and More: First Report of Successful Allogeneic Hematopoietic Cell Transplantation for Hepatopulmonary Syndrome Associated With Chronic Active Epstein-Barr Virus Disease.

It Takes a Village and More: First Report of Successful Allogeneic Hematopoietic Cell Transplantation for Hepatopulmonary Syndrome Associated With Chronic Active Epstein-Barr Virus Disease.

Journal: Pediatric blood & cancer

Published: May 05, 2025

Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.

Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.

Journal: Transplantation and cellular therapy

Published: April 07, 2025

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel.

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel.

Journal: Blood advances

Published: April 01, 2025

Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy.

Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy.

Journal: Transplantation and cellular therapy

Published: March 09, 2025

Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation.

Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation.

Journal: Blood

Published: January 31, 2025

A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633).

A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633).

Journal: Transplantation and cellular therapy

Published: January 08, 2025

A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease.

A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease.

Journal: Blood advances

Published: October 10, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026